S1 Guidelines for the Kaposi Sarcoma.

Autor: Esser S; HPSTD Outpatient Clinic, University Hospital of Dermatology Essen, University of Duisburg-Essen, Essen, Germany.; Institute for Translational HIV Research, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Schöfer H; Helios Dr. Horst Schmidt Kliniken, German Clinic for Diagnostics, Wiesbaden, Germany., Hoffmann C; ICH Study Center Hamburg, Hamburg, Germany.; Medical Clinic II, University of Schleswig-Holstein, Kiel Campus, Kiel, Germany., Claßen J; Clinic for Radiotherapy, Radiological Oncology and Palliative Medicine, ViDia Christian Clinics Karlsruhe, Karlsruhe, Germany., Kreuter A; Clinic for Dermatology, Venerology and Allergology, HELIOS St.-Elisabeth Hospital Oberhausen, University of Witten-Herdecke, Germany., Leiter U; Center for Dermatooncology, University Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Oette M; Clinic for General Internal Medicine, Gastroenterology, Infectiology, Augustinian Sisters Hospital, Cologne, Germany., Becker JC; Translational Skin Cancer Research, German Consortium for Translational Cancer Research (DKZK), University Medical Center Essen, Essen, Germany.; Clinic for Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Research Institute (DKFZ), Heidelberg, Germany., Ziemer M; Clinic for Dermatology, Venereology and Allergology, University Hospital Leipzig, Leipzig, Germany., Mosthaf F; Joint Practice for Hematology, Oncology and Infectiology Karlsruhe, Karlsruhe, Germany., Sirokay J; Clinic and Polyclinic for Dermatology and Allergology, University Hospital Bonn, Bonn, Germany., Ugurel S; Clinic for Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany., Potthoff A; WIR- Walk In Ruhr, Center for Sexual Health and Medicine, Clinic for Dermatology, Venerology and Allergology, Ruhr- University Bochum, Germany., Helbig D; Clinic and Polyclinic for Dermatology and Venereology, University Hospital Cologne, Cologne, Germany., Bierhoff E; Heinz Werner Seifert Institute for Dermatopathology Bonn, Bonn, Germany., Schulz TF; Institute of Virology, Hannover Medical School, Hannover, Germany., Brockmeyer NH; WIR- Walk In Ruhr, Center for Sexual Health and Medicine, Clinic for Dermatology, Venerology and Allergology, Ruhr- University Bochum, Germany., Grabbe S; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
Jazyk: angličtina
Zdroj: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2022 Jun; Vol. 20 (6), pp. 892-904. Date of Electronic Publication: 2022 Jun 03.
DOI: 10.1111/ddg.14788
Abstrakt: Kaposi's sarcoma (KS) is a rare, malignant, multilocular vascular disease originating from lymphatic endothelial cells that can primarily affect the skin and mucous membranes, but also the lymphatic system and internal organs such as the gastrointestinal tract, lungs or liver. Five epidemiological subtypes of KS with variable clinical course and prognosis are distinguished, with increased incidence in specific populations: (1) Classical KS, (2) Iatrogenic KS in immunosuppression, (3) Endemic (African) lymphadenopathic KS, (4) Epidemic, HIV-associated KS and KS associated with immune reconstitution inflammatory syndrome (IRIS), and (5) KS in men who have sex with men (MSM) without HIV infection. This interdisciplinary guideline summarizes current practice-relevant recommendations on diangostics and therapy of the different forms of KS. The recommendations mentioned in this short guideline are elaborated in more detail in the extended version of the guideline (online format of the JDDG).
(© 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
Databáze: MEDLINE